Security key
36338D108
Galera Therapeutics, Inc. - Common stock, par value $0.001 per share (the "Common Stock") (GRTX)
CUSIP: 36338D108
Q1 2024 13F Holders as of 31 Mar 2024
- Security type / class
- Equity / Common stock, par value $0.001 per share (the "Common Stock")
- Total 13F shares
- 9,781,540
- Total 13F value
- $1,369,942
- Share change
- -3,157,115
- SEC-reported price per share
- $0.14
- Number of holders
- 35
- Value change
- -$464,165
- Number of buys
- 12
- Number of sells
- 12
- Shares outstanding
- 203,337,158
Holder snapshot
6 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q1 2024
Institutions
35
Top holders
10
GRTX full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q1 2026
Galera Therapeutics, Inc. SEC filings
Galera Therapeutics, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 36338D108
Recent filing periods:
Ownership snapshot
Top reported holders of GRTX - Galera Therapeutics, Inc. - Common stock, par value $0.001 per share (the "Common Stock") (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
GSA CAPITAL PARTNERS LLP
Disclosed value leader
GSA CAPITAL PARTNERS LLP
Comparable rows
15/15
Latest evidence
31 Dec 2023
13F
Lead comparable stake: 1.9%
Showing 1-6 of 15 holder rows.
Quick read
GSA CAPITAL PARTNERS LLP leads the comparable SEC ownership view at 1.9%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens GSA CAPITAL PARTNERS LLP's linked filing trail.
Comparable ownership
Top 5
GSA CAPITAL PARTNERS LLP
1.9%
Sofinnova Investments, Inc.
1.5%
Blackstone Inc.
0.83%
Aberdeen Group plc
0.44%
Nan Fung Group Holdings Ltd
0.3%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| GSA CAPITAL PARTNERS LLP |
13F
Company
|
1.9%
|
$566,000
3,892,561 shares
|
— | 31 Dec 2023 |
| Sofinnova Investments, Inc. |
13F
Company
|
1.5%
|
$448,372
3,083,712 shares
|
— | 31 Dec 2023 |
| Blackstone Inc. |
13F
Company
|
0.83%
|
$243,453
1,678,984 shares
|
— | 31 Dec 2023 |
| Aberdeen Group plc |
13F
Company
|
0.44%
|
$130,624
898,374 shares
|
— | 31 Dec 2023 |
| Nan Fung Group Holdings Ltd |
13F
Company
|
0.3%
|
$89,163
613,223 shares
|
— | 31 Dec 2023 |
| CITADEL ADVISORS LLC |
13F
Company
|
0.29%
|
$85,794
590,052 shares
|
— | 31 Dec 2023 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q1 2024
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
35
Shares
9,781,540
Rows available
35
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q1 2024 vs Q1 2026 Across Filers
Q1 2026 holders
1
Q1 2024 holders
35
Holder diff
34
| Investor | Q1 2026 Shares | Q1 2024 Shares | Share Diff | Share Chg % | Q1 2026 value | Q1 2024 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend